ClinicalTrials.Veeva

Menu

A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

O

Olympus

Status

Completed

Conditions

Degenerative Lumbar Spondylolisthesis

Treatments

Device: Use of OP-1 Putty in Uninstrumented posterolateral fusion

Study type

Interventional

Funder types

Industry

Identifiers

NCT00679107
S99-01US

Details and patient eligibility

About

This study will explore the use of OP-1 Putty in conjunction with surgical treatment for the treatment of spinal decompression and lumbar spinal fusion.

Full description

It is postulated that the addition of OP-1 Putty to autogenous bone will prove beneficial in the treatment of patients requiring decompression and lumbar spinal fusion. The Investigational system is intended to stimulate bone growth. It is indicated as an adjunct or a replacement for autograft in spinal fusion.

Enrollment

48 patients

Sex

All

Ages

18 to 81 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The subject has a diagnosis of Degenerative Lumbar Spondylolisthesis of Grade I or II with Spinal Stenosis demonstrated by medical history, physical examination a n d radiographic imaging.
  2. The subject is a candidate for decompression and spinal fusion with the use of autograft from the iliac crest.
  3. The subject requires one level lumbar fusion (L-3 to S-1).
  4. The subject has a preoperative Oswestry Disability Index of 30-100.

Exclusion criteria

  1. The subject has active spinal and/or systemic infection.
  2. The subject is morbidly obese.
  3. The subject has a known sensitivity to any component of the OP-1 Putty.
  4. The subject has spinal instability measured on flexion / extension radiographs of greater than 50% translation of the vertebrae and greater than or equal to 20 degrees of angular motion.
  5. The subject uses tobacco or nicotine or is prescribed steroids such as cortisone.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

48 participants in 2 patient groups

1
Experimental group
Description:
autogenous bone graft with the addition of OP-1 Putty
Treatment:
Device: Use of OP-1 Putty in Uninstrumented posterolateral fusion
2
Active Comparator group
Description:
autogenous bone graft alone
Treatment:
Device: Use of OP-1 Putty in Uninstrumented posterolateral fusion

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems